Johannes Czernin

APLA Health — United States

Medicine · Health Sciences

95h-index27.1kcitations588works3.92yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Medical Imaging Techniques and Applications(209), Prostate Cancer Treatment and Research(186), Radiopharmaceutical Chemistry and Applications(181), Radiomics and Machine Learning in Medical Imaging(97), Prostate Cancer Diagnosis and Treatment(68)

Publications588 total

Linking Baseline PSMA PET–Derived Parameters to Toxicity, Adverse Events, Pain, and Quality of Life in Patients Treated with [ <sup>177</sup> Lu]Lu-PSMA-617: A Single-Center Retrospective Study
Journal of Nuclear Medicine·2025
Clinical Impact of Changes in Tumor Uptake and Volume on PSMA PET/CT During [ <sup>177</sup> Lu]Lu-PSMA Therapy in Metastatic Castration-Resistant Prostate Cancer
Journal of Nuclear Medicine·2025
FAP Expression in Renal Tumors Assessed by [ <sup>68</sup> Ga]Ga-FAPI-46 PET Imaging and FAP Immunohistochemistry: A Case Series of Six Patients from the Prospective Exploratory Trial NCT04147494
Journal of Nuclear Medicine·2025Open Access
SPARC: The Standardised Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Analysis and Reporting Consensus: A Delphi Analysis
European Urology·2025· 7 citedOpen Access
Translating Discovery into Impact
Journal of Nuclear Medicine·2025
Pooled Analysis of the SOLAR and SATURN Clinical Trials Comparing Progression of Synchronous Versus Metachronous Prostate-specific Membrane Antigen–defined Oligometastatic Prostate Cancer Following Systemic and Tumor-directed Therapy
European Urology Oncology·2025· 1 citedOpen Access
<i>JNM</i>Editors’ Choice Awards for 2024
Journal of Nuclear Medicine·2025
A randomized phase 2 trial of flexible and extended dosing of <sup>177</sup> Lu-PSMA-617 molecular radioligand therapy in mCRPC (FLEX-MRT): Trial in progress update.
Journal of Clinical Oncology·2025
Study protocol: Phase 2 trial of re-treatment with 177Lu-PSMA-617 molecular radiotherapy for metastatic castration resistant prostate cancer (RE-LuPSMA trial).
Journal of Clinical Oncology·2025
Early changes of PSMA PET expression after initiation of androgen receptor signaling inhibitors in CRPC: an international multicenter retrospective study
European Journal of Nuclear Medicine and Molecular Imaging·2025· 3 cited
Hematological toxicity of [225Ac]Ac-PSMA-617 and [177Lu]Lu-PSMA-617 in RM1-PGLS syngeneic mouse model
EJNMMI Radiopharmacy and Chemistry·2025· 5 citedOpen Access
Kinetics of PSMA PET signal after radiotherapy in prostate cancer lesions: A single-center retrospective study
Radiotherapy and Oncology·2025· 9 cited
Comparing progression following systemic and tumor-directed therapy for <i>de novo</i> versus recurrent PSMA PET–defined oligo-M1 prostate cancer: A pooled analysis of SOLAR and SATURN clinical trials.
Journal of Clinical Oncology·2025
Five-year follow-up of prostate specific membrane antigen PET/CT-guided salvage radiotherapy following radical prostatectomy: A single center retrospective analysis.
Journal of Clinical Oncology·2025
Reflections on the Demand for PSMA- and SSTR-Targeted Radiopharmaceutical Therapies: Why We Were Wrong (and Why We Will Be Right Eventually)
Journal of Nuclear Medicine·2025· 1 citedOpen Access
Abstract B001: Double targeted therapy PSCA-CAR-T cells and PSMA-radioligand in metastatic castration-resistant prostate cancer
Clinical Cancer Research·2025· 1 cited
Abstract P012: PSMA-RLT and targeting the cGAS-STING pathway as a combination approach for Prostate Cancer
Clinical Cancer Research·2025
Advancing Tomorrow’s Cancer Medicines
Journal of Nuclear Medicine·2025Open Access
From Scientist to Analyst to Strategist
Journal of Nuclear Medicine·2025Open Access
A comparative study of preclinical and clinical molecular imaging response to EGFR inhibition using osimertinib in glioblastoma
Neuro-Oncology Advances·2025· 1 citedOpen Access
page 1 of 30Next →

Frequent Co-authors

Ken Herrmann(12), Michael E. Phelps(11), Michael E. Phelps(10), Daniel Silverman(9), Wolfgang P. Fendler(9), Jérémie Calais(8), Matthias Eiber(8), Heinrich R. Schelbert(8), Martin Allen-Auerbach(7), Thomas A. Hope(6), Wolfgang Weber(6), Heiko Schöder(5), Nagichettiar Satyamurthy(5), Christiaan Schiepers(5), Timothy F. Cloughesy(5), Sanjiv S. Gambhir(4), Carl K. Hoh(4), Robert E. Reiter(4), Matthew B. Rettig(4), Roger Slavik(4)